SNCA and Parkinson disease: With a continually increasing disease burden of nearly 10 million patients worldwide [1], Parkinson’s disease (PD) is a devastating neurodegenerative disorder that is characterized by the loss of multiple neuronal populations and the aggregation of α-synuclein protein into intracellular inclusions known as Lewy bodies (LBs) [2,3].